Legal & General Group’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
50,418
+825
| +2% | +$19.4K | ﹤0.01% | 2181 |
|
|
2025
Q1 | $1.19M | Buy |
49,593
+1,784
| +4% | +$42.8K | ﹤0.01% | 2120 |
|
|
2024
Q4 | $2.02M | Buy |
47,809
+8,313
| +21% | +$352K | ﹤0.01% | 1978 |
|
|
2024
Q3 | $1.75M | Buy |
39,496
+123
| +0.3% | +$5.44K | ﹤0.01% | 2037 |
|
|
2024
Q2 | $1.42M | Buy |
39,373
+1,661
| +4% | +$60.1K | ﹤0.01% | 2075 |
|
|
2024
Q1 | $1.63M | Buy |
37,712
+12,722
| +51% | +$549K | ﹤0.01% | 2018 |
|
|
2023
Q4 | $384K | Hold |
24,990
| – | – | ﹤0.01% | 2553 |
|
|
2023
Q3 | $343K | Buy |
24,990
+21,373
| +591% | +$293K | ﹤0.01% | 2583 |
|
|
2023
Q2 | $58.1K | Buy |
3,617
+1,038
| +40% | +$16.7K | ﹤0.01% | 2861 |
|
|
2023
Q1 | $20K | Sell |
2,579
-3,327
| -56% | -$25.8K | ﹤0.01% | 3065 |
|
|
2022
Q4 | $114K | Buy |
5,906
+520
| +10% | +$10.1K | ﹤0.01% | 2789 |
|
|
2022
Q3 | $114K | Buy |
5,386
+488
| +10% | +$10.3K | ﹤0.01% | 2778 |
|
|
2022
Q2 | $67K | Buy |
4,898
+3,591
| +275% | +$49.1K | ﹤0.01% | 2947 |
|
|
2022
Q1 | $31K | Buy |
1,307
+374
| +40% | +$8.87K | ﹤0.01% | 3120 |
|
|
2021
Q4 | $25K | Buy |
933
+271
| +41% | +$7.26K | ﹤0.01% | 3204 |
|
|
2021
Q3 | $12K | Buy |
+662
| New | +$12K | ﹤0.01% | 3421 |
|